PDCD1 and melanoma: A prospective clinical study shows that peripheral blood mononuclear cells (PBMCs) of melanoma patients who responded to PD-1 antibody had increased glycolysis, fatty acid metabolism, and tryptophan and branched chain amino acid metabolism, which supports increased mitochondrial function under stress (55).